Provided by Tiger Trade Technology Pte. Ltd.

BioDelivery Sciences

5.59
0.0000
Volume:- -
Turnover:- -
Market Cap:577.05M
PE:6.82
High:5.59
Open:5.59
Low:5.59
Close:5.59
52wk High:5.62
52wk Low:2.50
Shares:103.23M
Float Shares:86.76M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8544
ROE:57.33%
ROA:8.22%
PB:3.07
PE(LYR):6.54

Loading ...

Company Profile

Company Name:
BioDelivery Sciences
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products for chronic conditions in the United States and internationally. The company provides its products based on its patented BioErodible MucoAdhesive drug-delivery technology, a small erodible polymer film for application to the buccal mucosa, as well as other drug-delivery technologies. It offers BELBUCA, a buprenorphine buccal film for the treatment of chronic pain; BUNAVAIL, a buprenorphine and naloxone buccal film to treat opioid dependence; and ONSOLIS, a fentanyl buccal soluble film for the management of breakthrough pain in cancer patients. The company also offers Symproic, a peripherally acting mu-opioid receptor antagonist for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain, including patients with chronic pain related to prior cancer or its treatment who do not require frequent opioid dosage escalation. BioDelivery Sciences International, Inc. was incorporated in 1997 and is headquartered in Raleigh, North Carolina.